G1

G1 is a botanical cannabis formulation developed by Tikun Olam USA, specifically engineered for the management of digestive disorders, including inflammatory bowel disease (IBD) such as Crohn's disease and ulcerative colitis. This formulation leverages the therapeutic properties of specific cannabinoid and terpene profiles to target the endocannabinoid system within the gastrointestinal tract. By activating cannabinoid receptors, G1 aims to reduce intestinal inflammation, modulate gut motility, and alleviate visceral pain, thereby improving digestive comfort and clinical outcomes for patients. Tikun Olam has conducted several clinical studies demonstrating the efficacy of their standardized cannabis strains in inducing clinical remission and improving quality of life in patients with refractory IBD.

Other names

Tikun Olam digestive formulationTikun Olam botanical cannabis formulationTikun Olam digestive comfort formulation